Education Library

Vasileios Panoulas, MD, discusses a pooled analysis of factors predicting outcomes at 90 days in high-risk PCI patients.

Learn more about the data and differences between part I and part II from the York data analysis.

In the presentation titled “Predictive value of residual SYNTAX score for clinical outcomes after high-risk percutaneous coronary intervention: Evidence from pooled analysis of prospective studies.”

In a third-party analysis conducted by the York Health Economics Consortium, IPD from contemporary studies were evaluated to test the hypothesis that PCI with Impella® support may be associated with a greater extent of revascularization.

Viktoriya Kagan, AGACNP-BC, CCRN, and Eddy Gutierrez, MD, discuss how to care for patients with cardiogenic shock and manage Impella® in the ICU.

Vasileios Panoulas, MD, discusses an individual patient data pooling from the PROTECT II RCT, PROTECT III and RESTORE EF trials released at EuroPCR 2023.

Prof. Dr. Evgenij V. Potapov discusses combining extracorporeal life support (ECLS) with pMCS for treating advanced cardiogenic shock.

Alaide Chieffo, MD, discusses results from a subanalysis of women in the IMP-IT Registry in Italy.

Are there billable services after Impella® insertion in the cath lab, such as ICU monitoring?

Jacob Abraham, MD, Raymond Lee, MD, and Bindu Akkanti, MD, discuss ECpella therapy in this CAMP webinar moderated by Misty Casseus, MSN, RN.

Learn how to place a mattress suture during explant of the Impella RP® with SmartAssist® in the ICU.

Rohan Goswami, MD, discusses renal recovery in patients with heart failure cardiogenic shock (HFCS) supported with Impella 5.5® with SmartAssist®.

Gregg Stone, MD, FACC, FSCAI interviews Prof. Divaka Perera, professor of cardiology at Kings College in London, UK at the European Society of Cardiology (ESC) Congress 2022 in Barcelona, Spain.

Vijay Iyer, MD, discusses important concepts being explored in the STEMI-DTU™ trial, emphasizing that unloading is not delaying treatment. 

Jay Giri, MD, discusses the pros, cons, and best uses for five types of observational database analyses.